PT1265904E - Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento - Google Patents

Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento

Info

Publication number
PT1265904E
PT1265904E PT01911553T PT01911553T PT1265904E PT 1265904 E PT1265904 E PT 1265904E PT 01911553 T PT01911553 T PT 01911553T PT 01911553 T PT01911553 T PT 01911553T PT 1265904 E PT1265904 E PT 1265904E
Authority
PT
Portugal
Prior art keywords
preparation
treatment
pharmaceutically acceptable
acceptable carrier
relates
Prior art date
Application number
PT01911553T
Other languages
English (en)
Inventor
Thomas Weiser
Karin Winter
Stefan Matthias Blech
Angelo Ceci
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of PT1265904E publication Critical patent/PT1265904E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Urology & Nephrology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PT01911553T 2000-02-02 2001-01-30 Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento PT1265904E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10004572A DE10004572A1 (de) 2000-02-02 2000-02-02 Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Publications (1)

Publication Number Publication Date
PT1265904E true PT1265904E (pt) 2004-11-30

Family

ID=7629599

Family Applications (1)

Application Number Title Priority Date Filing Date
PT01911553T PT1265904E (pt) 2000-02-02 2001-01-30 Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento

Country Status (16)

Country Link
US (3) US6525045B2 (pt)
EP (1) EP1265904B1 (pt)
JP (1) JP4891510B2 (pt)
AR (1) AR027352A1 (pt)
AT (1) ATE277054T1 (pt)
AU (1) AU2001240561A1 (pt)
CA (1) CA2399377C (pt)
CO (1) CO5261505A1 (pt)
DE (2) DE10004572A1 (pt)
DK (1) DK1265904T3 (pt)
ES (1) ES2228817T3 (pt)
MX (1) MXPA02007460A (pt)
PT (1) PT1265904E (pt)
TR (1) TR200402650T4 (pt)
UY (1) UY26566A1 (pt)
WO (1) WO2001057045A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
NZ520588A (en) * 2000-03-21 2004-06-25 Smithkline Beecham Corp Protease inhibitors
KR100982753B1 (ko) * 2001-04-05 2010-09-16 콜라제넥스 파마슈티칼스, 인크 테트라사이클린 화합물 및 테트라사이클린 유도체의 전달조절
US20030100552A1 (en) 2001-05-17 2003-05-29 Boehringer Ingelheim Pharma Kg Positive allosteric AMPA receptor modulators (PAARM), processes for preparing them, and their use as pharmaceutical compositions
DE10123952A1 (de) * 2001-05-17 2002-11-21 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
CA2458388A1 (en) * 2001-10-10 2003-04-17 Neurosearch A/S Novel benzothiazine derivatives, their preparation and use
US7815391B2 (en) * 2004-07-23 2010-10-19 Kauppila Richard W Structural member joints
US20060063707A1 (en) * 2004-09-17 2006-03-23 Lifelike Biomatic, Inc. Compositions for enhancing memory and methods therefor
AU2009243730B2 (en) * 2008-05-05 2013-07-18 Polypeptide Laboratories Holding (Ppl) Ab Indolesulfonyl protecting groups for protection of guanidino and amino groups
US20110218190A1 (en) * 2008-11-10 2011-09-08 The Regents Of The University Of California Therapeutic uses of ampa receptor modulators for treatment of motor dysfunction
BR112015031249A2 (pt) 2013-06-13 2017-07-25 Veroscience Llc método de tratamento, método para tratar um distúrbio metabólico ou um elemento chave do mesmo, método para normalizar um ritmo diário de liberação de dopamina no sumn, método para estimular a liberação de dopamina de neurônios dopaminérgicos no sumn de um indivíduo e composição farmacêutica

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8724566D0 (en) * 1987-10-20 1987-11-25 Roussel Lab Ltd Chemical compounds
US4994452A (en) * 1989-11-28 1991-02-19 Hoechst-Roussel Pharmaceuticals Inc. Hexahydro-1H-quino[4,3,2-ef][1,4]benzoxazepines and related compounds
AU3957093A (en) * 1992-04-15 1993-11-18 Rhone-Poulenc Rorer S.A. 3,4-dihydro-2H-1,2,4-benzothiadiazine-1,1-dioxide-3-carboxyl ic acid derivatives, preparation thereof and drugs containing same
ES2149989T3 (es) * 1994-05-24 2000-11-16 Hoffmann La Roche Derivados triciclicos de dicarbonilo.
US5891871A (en) * 1996-03-21 1999-04-06 Cocensys, Inc. Substituted 2,3-benzodiazepin-4-ones and the use thereof
WO1998012185A1 (en) * 1996-09-17 1998-03-26 The Regents Of The University Of California Benzothiadiazide derivatives and their use as allosteric up-modulators of the ampa receptor
US5968928A (en) * 1996-09-19 1999-10-19 Warner-Lambert Company Excitatory amino acid antagonists: fused-azacyclic quinoxalinediones and immunoassays thereof
US5969138A (en) * 1996-11-01 1999-10-19 Mitsui Chemicals, Inc. Pyrrolidinone derivatives
US5985871A (en) * 1997-12-24 1999-11-16 Cortex Pharmaceuticals, Inc. Benzoxazine compounds for enhancing synaptic response
ZA991301B (en) * 1998-02-18 1999-09-13 Neurosearch As Glutamate receptor modulators.
US6096744A (en) * 1998-05-04 2000-08-01 Warner-Lambert Company Sulfonamide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
DE10004572A1 (de) * 2000-02-02 2001-08-09 Boehringer Ingelheim Pharma Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel

Also Published As

Publication number Publication date
CA2399377C (en) 2008-12-16
MXPA02007460A (es) 2003-01-28
US20030158181A1 (en) 2003-08-21
US20030158183A1 (en) 2003-08-21
TR200402650T4 (tr) 2004-11-22
ES2228817T3 (es) 2005-04-16
US6800623B2 (en) 2004-10-05
AR027352A1 (es) 2003-03-26
DE10004572A1 (de) 2001-08-09
JP2003522180A (ja) 2003-07-22
DE50103760D1 (de) 2004-10-28
UY26566A1 (es) 2001-08-27
WO2001057045A1 (de) 2001-08-09
EP1265904A1 (de) 2002-12-18
EP1265904B1 (de) 2004-09-22
CO5261505A1 (es) 2003-03-31
DK1265904T3 (da) 2004-10-25
ATE277054T1 (de) 2004-10-15
US20020013313A1 (en) 2002-01-31
JP4891510B2 (ja) 2012-03-07
AU2001240561A1 (en) 2001-08-14
CA2399377A1 (en) 2001-08-09
US6525045B2 (en) 2003-02-25

Similar Documents

Publication Publication Date Title
DK1263729T3 (da) Cykliske azaforbindelser til anvendelse til behandling af serotoninrealterede sygdomme
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
BR0210855A (pt) Método de fabricação de formulações de liberação prolongada
HK1026691A1 (en) Substituted benzimidazoles and their use for treating retroviral infection
MX9707453A (es) Derivados de quinazolina.
SE0100568D0 (sv) Compounds
ATE342728T1 (de) Zubereitung zur behandlung von einer neurologischen erkrankung
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
ATE375341T1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
HK1069339A1 (en) Substituted diketopiperazines as oxytocin antagonists
SE0104248D0 (sv) Method of treatment
CY1111396T1 (el) Ρινικη χορηγηση μετοκλοπραμιδης για την αγωγη της γαστροπαρεσης
PT1265904E (pt) Novos moduladores alostericos positivos de receptores ampa (paarm) processo paraa sua preparacao e sua utilizacao como medicamento
IL162384A0 (en) Composition inhibiting matrix-metallproteinases for the treatment of neoplastic diseases
SE0100566D0 (sv) Compounds
DE60026491D1 (de) Melagatran zur behandlung von entzündungen
SE0004101D0 (sv) New use
SE0101692D0 (sv) Compounds
NO20003481L (no) FremgangsmÕte for behandling av COPD
DE60114597D1 (de) Naphthamid-neurokinin antagonisten zur verwendung als medikamente
MXPA03010737A (es) Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion.
HUP9904578A2 (hu) Xanomelin alkalmazása bipoláris depresszió kezelésére szolgáló gyógyszerkészítmények előállítására
DE60121978D1 (de) 7-CHLOR-4-HYDROXY-2-(2-PYRIDYLETHYL)-1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BöCHINOLIN-1,10-DIONE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON SCHMERZEN
ATE301997T1 (de) Antivirale therapie